Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E Adjustments
Ratios

Aptevo Therapeutics (APVO) Receivables - Other (2020 - 2022)

Aptevo Therapeutics' Receivables - Other history spans 3 years, with the latest figure at $3.1 million for Q1 2022.

  • For Q1 2022, Receivables - Other rose 28.62% year-over-year to $3.1 million; the TTM value through Mar 2022 reached $3.1 million, up 28.62%, while the annual FY2021 figure was $3.7 million, 54.66% up from the prior year.
  • Receivables - Other for Q1 2022 was $3.1 million at Aptevo Therapeutics, down from $3.7 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $3.7 million in Q4 2021 and bottomed at $288000.0 in Q2 2020.
  • The 3-year median for Receivables - Other is $2.8 million (2021), against an average of $2.4 million.
  • The largest annual shift saw Receivables - Other surged 979.86% in 2021 before it rose 28.62% in 2022.
  • A 3-year view of Receivables - Other shows it stood at $2.4 million in 2020, then surged by 54.66% to $3.7 million in 2021, then dropped by 15.01% to $3.1 million in 2022.
  • Per Business Quant, the three most recent readings for APVO's Receivables - Other are $3.1 million (Q1 2022), $3.7 million (Q4 2021), and $3.1 million (Q3 2021).